PF-05082566 + KW-0761
Phase 1Terminated 1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced/Metastatic Solid Tumors
Conditions
Advanced/Metastatic Solid Tumors
Trial Timeline
May 1, 2015 → Oct 1, 2017
NCT ID
NCT02444793About PF-05082566 + KW-0761
PF-05082566 + KW-0761 is a phase 1 stage product being developed by Kyowa Kirin for Advanced/Metastatic Solid Tumors. The current trial status is terminated. This product is registered under clinical trial identifier NCT02444793. Target conditions include Advanced/Metastatic Solid Tumors.
What happened to similar drugs?
0 of 2 similar drugs in Advanced/Metastatic Solid Tumors were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02444793 | Phase 1 | Terminated |
Competing Products
20 competing products in Advanced/Metastatic Solid Tumors